Price target upside
CG Oncology Price Target: +52.2% vs Current Price
Direct answer
CG Oncology's analyst target implies +52.2%.
The average target is $91.08 compared with a recorded current price of $59.85.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 18, 2026.
Get free CG Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $59.85
- Average price target
- $91.08
- High price target
- $108.00
- Low price target
- $79.00
- Low target gap
- +32%
- Target upside
- +52.2%
- High target gap
- +80.5%
- Target range width
- 48.5%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does CG Oncology's average target imply?
CG Oncology's average target is $91.08 versus a recorded price of $59.85. The difference is +52.2%.
How far are CG Oncology's low and high targets from the recorded price?
The low target implies +32%, while the high target implies +80.5%.
How many analysts are included in CG Oncology's consensus?
The verified consensus includes 13 analysts.
How is CG Oncology's target upside or downside calculated?
The average target of $91.08 is divided by the recorded price of $59.85, then one is subtracted to produce +52.2%. This does not guarantee a future return.
When was CG Oncology's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.